![Michael Morrissey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 147 M $ al 31/01/2026
En la actualidad, Michael M. Morrissey ocupa el cargo de presidente, director general y consejero de Exelixis, Inc. El Dr. Morrissey también forma parte del consejo de administración de XWPharma Ltd. En su anterior carrera, el Dr. Morrissey ocupó el puesto de científico principal en Ciba-Geigy Corp. y de vicepresidente de investigación de descubrimientos en Berlex Biosciences. Michael M. Morrissey se doctoró en la Universidad de Harvard y se licenció en la Universidad de Wisconsin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EXELIXIS, INC. 1,33 % | 15/01/2026 | 3.557.373 ( 1,33 % ) | 147 M $ | 31/01/2026 |
| 14/05/2025 | 0 ( -.--% ) | - $ | 31/01/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EXELIXIS, INC. | Director Ejecutivo | 22/07/2010 |
| VERA THERAPEUTICS, INC. | Presidente | 24/05/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
XWPharma Ltd.
 XWPharma Ltd. Develops drug products for neurological disorders | Director/Miembro de la Junta | 01/04/2023 |
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. Engages in development of engineered T-cell therapeutics for the treatment of cancer | Director/Miembro de la Junta | 01/11/2022 |
Berlex Biosciences | Corporate Officer/Principal | 01/01/2000 |
Ciba-Geigy Corp.
 Ciba-Geigy Corp. Manufactures physician and surgical equipment | Director Técnico/Científico/I+D | 01/01/1991 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Ciba-Geigy Corp.
Ciba-Geigy Corp. Manufactures physician and surgical equipment | |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Develops drug products for neurological disorders | |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Engages in development of engineered T-cell therapeutics for the treatment of cancer | |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition
